Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.
Open accessThe DOI matches its Crossref record.
Abstract
Purified human lung mast cells released histamine, leukotrienes, prostaglandin (PG) D2, thromboxane B2 (TxB2), and PGF2 alpha in response to anti-IgE stimulation. Incubation of the cells for 24 h with 10(-6) M dexamethasone, a treatment that inhibits mediator release from human basophils, had no effect on the release of these mediators from mast cells. Dexamethasone treatment of human lung fragments led to little or no inhibition of anti-IgE-induced release of the mast cell-derived mediator, histamine, but produced a significant inhibition of the release of PGE2, PGF2 alpha, and 6-keto-PGF1 alpha. As was the case with purified mast cells, the steroid did not inhibit the release of PGD2 or TxB2 from human lung fragments. Comparison of the quantities of PGD2 and TxB2 produced by purified cells and human lung fragments reveals that the mast cells produce quantities of these metabolites sufficient to account for the entire amount produced by challenged lung fragments. Dexamethasone inhibited spontaneous release from lung fragments of all cyclooxygenase products measured. These results suggest that the human lung parenchymal mast cell phospholipase is not inhibited by dexamethasone, whereas other phospholipase(s) in the lung are inhibited by the steroid. These results may be useful in explaining the resistance of acute allergic reactions, including anaphylaxis, to steroids, despite the potent antiinflammatory activity of steroids on subacute and chronic inflammation, such as in bronchial asthma, which may be initiated by IgE-dependent mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
Efficacy and Safety of Inhaled Corticosteroids: New Developments
BARNES, P. J., PEDERSEN, S., & BUSSE, W. W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.157315 · Cited by 749
Galli, S. J. (1990) · Pathology Reviews • 1990 · doi:10.1007/978-1-4612-0485-5_5 · Cited by 615
Efficacy and Safety of Inhaled Corticosteroids in Asthma
Barnes, P. J., & Pedersen, S. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.4_pt_2.s1 · Cited by 523
Galli, S. J. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200001000-00007 · Cited by 521
IgE, Mast Cells, and Eosinophils in Atopic Dermatitis
Liu, F.-T., Goodarzi, H., & Chen, H.-Y. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8252-4 · Cited by 470
A New Approach to the Treatment of Asthma
Oates, J. A., Wood, A. J. J., & Barnes, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212206 · Cited by 450
Basophil influx occurs after nasal antigen challenge: Effects of topical corticosteroid pretreatment
Bascom, R., Wachs, M., Naclerio, R. M., Pipkorn, U., Galli, S. J., & Lichtenstein, L. M. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90198-4 · Cited by 306
Self-citationEffect of oral prednisone on airway inflammatory mediators in atopic asthma.
Dworski, R., Fitzgerald, G. A., Oates, J. A., & Sheller, J. R. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.4.8143061 · Cited by 289
Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway
Broide, D. H., Gleich, G. J., Cuomo, A. J., Coburn, D. A., Federman, E. C., Schwarte, L. B., & Wasserman, S. I. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90158-k · Cited by 282
Pipkorn, U., Proud, D., Lichtenstein, L. M., Kagey-Sobotka, A., Norman, P. S., & Naclerio, R. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162403 · Cited by 255
Self-citationAn overview of glucocorticoid anti-inflammatory actions
Schleimer, R. P. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf01844196 · Cited by 199
“Interestingly, the mast cell, a tissue-bound relative of the basophil, is quite resistant to GC effects in human (though in murine species, mast cells are inhibited by GCs) [20, 21].”
BackgroundSelf-citationPipkorn, U., Proud, D., Lichtenstein, L. M., Schleimer, R. P., Peters, S. P., Adkinson, N. F., Kagey-Sobotka, A., Norman, P. S., & Naclerio, R. M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113188 · Cited by 158
Self-citationDes Roches, A., Paradis, L., Bougeard, Y.-H., Godard, P., Bousquet, J., & Chanez, P. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70085-4 · Cited by 64
Butterfield, J., & Weiler, C. R. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.02.021 · Cited by 41
Skin reactivity to codeine and histamine during prolonged corticosteroid therapy
Olson, R., Henry Karpink, M., Shelanski, S., Atkins, P. C., & Zweiman, B. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80060-0 · Cited by 38
Andersson, M., & Pipkorn, U. (1987) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(87)90153-9 · Cited by 34
Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome
Butterfield, J. H. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.02.017 · Cited by 30
Butterfield, J. H. (2022) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.03.008 · Cited by 27
Metadata
- Authors
- Schleimer, R. P., Schulman, E. S., MacGlashan, D. W., Peters, S. P., Hayes, E. C., Adams, G. K., Lichtenstein, L. M., & Adkinson, N. F.
- Venue
- Journal of Clinical Investigation
- Published
- 1983-06-01
- Volume
- 71
- Issue
- 6
- Pages
- 1830-1835
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2040514575
- Cited by
- 219
- References
- 0
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.